Results

Total Results: 2,034 records

Showing results for "time".

2021. PEPTIC ULCER #11 (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/11_pepticulcer_potential_high_impact_june_2012.pdf
      January 01, 2012 - Rifaximin for treatment of nonconstipating irritable bowel syndrome No high-impact potential at this time … such as POEM might offer potential benefits including greater surgical precision, a shorter recovery time … case series, patients with achalasia (n=5) underwent successful POEM treatment with a mean operative time … procedure that could provide a permanent, minimally invasive treatment option with shorter recovery time … the small intestine, surgical options can enhance the surface area of the intestine or lengthen the time

2022. Disposition of Comments Report for Prevention of Healthcare-Associated Infections (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/related_files/health-careassociated-infections_disposition-comments.pdf
      November 30, 2012 - Virtually every serious article on the subject emphasizes the role of real time data to guide testing … Although SPC is widely used in evaluating the impact of QI efforts in real time, SPC generally does … Most good time series studies use many more data points as this allows a view on variability over time … Improvement science emphasizes understanding data over time AND variation. … for most investigators than a trial design and because interrupted time series were common in the

2023. Meeting Summary (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/pdf/stakeholders-engagement-others_slides-2011.pdf
      January 01, 2011 - Identifying roadblocks to their participation (e.g., financial or time constraints) is important. … Planning activities such as teleconferences outside of normal work hours can reduce the burden of taking time … In addition, it affirms that the time and effort representatives spend engaging with researchers has … Presenting a clear timeline and anticipated time commitment at each stage of the project is also … facilitate opportunities for patient/consumer representatives to voice their thoughts and allow them time

2024. Pharmacologic and Nonpharmacologic Treatments of Post-Traumatic Stress Disorder (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/related_files/ptsd-protocol.pdf
      July 10, 2018 - Assessment time points for primary PTSD outcome y. … Number of participants who completed measurement for primary PTSD outcome measure at each time point … size on primary PTSD outcome measure, by condition at posttreatment and each available follow up time … Between group effect size for primary PTSD outcome at posttreatment and each available follow up time … Within group effect size for primary PTSD outcome at posttreatment and followup time points* k.

2025. Pharmacologic and Nonpharmacologic Treatments of Post-Traumatic Stress Disorder (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/pdf/ptsd-protocol.pdf
      July 10, 2018 - Assessment time points for primary PTSD outcome y. … Number of participants who completed measurement for primary PTSD outcome measure at each time point … size on primary PTSD outcome measure, by condition at posttreatment and each available follow up time … Between group effect size for primary PTSD outcome at posttreatment and each available follow up time … Within group effect size for primary PTSD outcome at posttreatment and followup time points* k.

2026. Traumatic-Brain-Injury-Rehabilitation Research-Protocol (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/pdf/traumatic-brain-injury-rehabilitation_research-protocol.pdf
      October 25, 2010 - improvements in outcomes achieved via multidisciplinary postacute rehabilitation for TBI sustained over time … We will examine differences in effectiveness by injury characteristics such as etiology, time since … Adverse effects of treatment (KQ 5) (KQ 2) TBI characteristics Severity Injury type Time

2027. Untitled (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/pdf/thromboembolism-update_research-protocol.pdf
      February 17, 2016 - include placebo or no VTE prophylaxis •   KQ 6 Same intervention started at different (later) time … pre test* OR posttest* OR post test* OR prepost* OR pre post* OR “before and after” OR interrupted time … * OR time serie* OR intervention* OR (("quasi-experiment*" OR quasiexperiment* OR quasi or experimental … pre test* OR posttest* OR post test* OR prepost* OR pre post* OR (before and after) OR interrupted time … * OR time serie* OR intervention* OR ((quasi-experiment* OR quasiexperiment* OR quasi or experimental

2028. Disposition of Comments for CER 211: Drug Therapy for Early Rheumatoid Arthritis: A Systematic Review Update (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-211-rheumatoid-arthritis-disposition-comments.pdf
      December 20, 2018 - Unfortunately, not possible at this time. … Rationale: Because time may be an important effect modifier, combining all time points may introduce … for this time period than for other ones. … Please consider including real-world data, especially registry data, as these studies include data on long … term effects and follow-up.

2029. Microsoft Word - Comparative_Effectiveness_Research_Review_Disposition_of_Comments_Report_Final_120710_refs_delinked1.docx (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/related_files/autism_disposition-comments.pdf
      November 01, 2010 - Studies of this type can be helpful in assessing response to treatment in very short time frames and … Studies of this type can be helpful in assessing response to treatment in very short time frames and … We note also that at this time, researchers have been unable to clearly identify which children are … Studies of this type can be helpful in assessing response to treatment in very short time frames and … Tables Table 10 – I had a hard time figuring out what the table was illustrating.

2030. Research White Paper Registries in Accountable Care Addendum Registries for Evaluating Patient Outcomes Third Edition (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/accountable-care-registries-guide-3rd-ed-addendum-white-paper-2018-5.pdf
      January 01, 2018 - Medicaid Services’ (CMS) portfolio of accountable care organization (ACO) models was current at the time … Any one or more of these elements may have changed over time. … patients… [ensuring] that patients, especially the chronically ill, get the right care at the right time … The timely availability of data also requires real-time or near-real-time reporting. … The challenges of providing real-time data to a registry are considerable.

2031. Diabetes-Drugs-Utilization Research (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/pdf/diabetes-drugs-utilization_research.pdf
      March 01, 2011 - thiazoli- dinedione, the latter representing a considerable decreasing trend in utili- zation over time … In contrast to biguanides, use of sulfonylureas decreased over time. … for a thiazolidinedione, the latter representing a considerable decreasing trend in utilization over time … 2009) had a claim for a thiazolidinedione, both representing decreasing trends in utilization over time … 2008 2009 The decrease in utilization of this class of medi- cation was geographically uniform over time

2032. PEPTIC ULCER #11 (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/peptic-ulcer-horizon-scan-high-impact-1506.pdf
      June 01, 2015 - changes, the list of topics designated as having potentially high impact is expected to change over time … for treatment of diarrhea- predominant irritable bowel syndrome No high-impact potential at this time … treatment of moderate to severe ulcerative colitis and Crohn’s disease No high-impact potential at this time … Some commenters surmised that the drug’s high cost, over time, could reduce or eliminate any potential

2033. Ch 1-User-Guide-To-Ocer 130129 (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/ch_1-user-guide-to-ocer_130129.pdf
      August 13, 2012 - Framework For a particular question, what study populations, interventions, comparisons, outcomes, time … If stakeholders have a need to make decisions within a critical time frame for regulatory, ethical, … While a phased approach to research may postpone the time when a conclusive decision can be reached … Timing What is the time frame of interest for assessing outcomes? … are also practical tradeoffs that need to be considered in terms of research resources, like the time

2034. Insomnia_protocol-140403 (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/pdf/insomnia_research-protocol.pdf
      April 03, 2014 - symptoms such as sleep-onset latency, number of awakenings, wake after sleep onset, and total sleep time … Sleep efficiency (total sleep time/total time in bed) is a broader sleep measure that may capture the … parameters are objectively measured with polysomnography (measuring sleep continuity parameters, sleep time … sleep-onset latency (SOL), number of awakenings (NOA), wake after sleep onset (WASO), total sleep time … (TST), sleep efficiency [(TST) total sleep time/total time in bed], or questionnaires [Athens Insomnia